Login to Your Account



China’s Beigene plans $100M Nasdaq debut

By Shannon Ellis
Staff Writer

Monday, October 19, 2015
SHANGHAI – Clinical-stage immuno-oncology company, Beigene Co. Ltd., of Beijing, has announced its intention to raise $100 million on Nasdaq.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription